These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30035130)

  • 1. Inflammation in the Tumor Microenvironment.
    Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X
    J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130
    [No Abstract]   [Full Text] [Related]  

  • 2. STING signaling: a key to therapeutic tumor immunity.
    Foote JB; Emens LA
    Immunotherapy; 2018 Jul; 10(9):729-731. PubMed ID: 30008260
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant.
    Overwijk WW
    Curr Opin Immunol; 2017 Aug; 47():103-109. PubMed ID: 28806603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
    Sasidharan Nair V; Elkord E
    Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Role of Treg in Cancer.
    Frydrychowicz M; Boruczkowski M; Kolecka-Bednarczyk A; Dworacki G
    Scand J Immunol; 2017 Dec; 86(6):436-443. PubMed ID: 28941312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 8. Addressing tumour tolerance to improve cancer immunotherapy.
    Meyer RG; Herr W
    Eur J Immunol; 2010 Dec; 40(12):3302-5. PubMed ID: 21110313
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
    Ma W; Chen X; Yuan Y
    Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent progress in GM-CSF-based cancer immunotherapy.
    Yan WL; Shen KY; Tien CY; Chen YA; Liu SJ
    Immunotherapy; 2017 Mar; 9(4):347-360. PubMed ID: 28303764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinhibitory Pathways in Immunotherapy for Cancer.
    Baumeister SH; Freeman GJ; Dranoff G; Sharpe AH
    Annu Rev Immunol; 2016 May; 34():539-73. PubMed ID: 26927206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells, as a target in anticancer immunotherapy.
    Enokida T; Nishikawa H
    Immunotherapy; 2017 Jun; 9(8):623-627. PubMed ID: 28653572
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of heterogeneous regulatory T cells in the tumor microenvironment.
    Wei T; Zhong W; Li Q
    Pharmacol Res; 2020 Mar; 153():104659. PubMed ID: 31982490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory T cells in cancer immunotherapy].
    Nishikawa H
    Rinsho Ketsueki; 2014 Oct; 55(10):2183-9. PubMed ID: 25297785
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Tumor immunology meets oncology (TIMO) VI" from 7th to 8th of May 2010 in Halle, Germany.
    Quandt D; Massa C; Seliger B
    Cancer Immunol Immunother; 2011 Feb; 60(2):299-303. PubMed ID: 20803010
    [No Abstract]   [Full Text] [Related]  

  • 18. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibodies in plants for cancer immunotherapy.
    Moussavou G; Ko K; Lee JH; Choo YK
    Biomed Res Int; 2015; 2015():306164. PubMed ID: 26550566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.